PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseases
Lankin, Vadim Z.
;
Tikhaze, Alla K.
;
Viigimaa, Margus
;
Chazova, Irina Evgenevna
Terapevticheskii Arkhiv
2018
/
p. 27-30
https://doi.org/10.26442/terarkh201890927-30
Journal metrics at Scopus
Article at Scopus
Journal metrics at WOS
Article at WOS